ClotProtect raises €1.4M Seed round

18 February 2026· Leeds, United Kingdom· health, defense, biotech, b2b, b2g, deep_hardware

The funding will be used to further develop ClotProtect's technology, progress regulatory and clinical pathways, and support commercial growth as the company prepares to scale.

Taking part in the Elevate Her Accelerator was a turning point for ClotProtect. The support, mentorship and belief from the Lifted team, particularly from Jordan, has been instrumental in helping us secure Innovate UK funding and close this £1.2m round. This investment gives us the platform to scale faster and bring our technology to more patients who need it.

Helen Philippou, founder

Investors

LeadLifted Ventures
Also participating
Innovate UKLifted Ventures Angel Network

About ClotProtect

Stage
Seed
Headquarters
Leeds, United Kingdom
Founded
2024
Team Size
6–20
Sectors
healthdefensebiotechb2bb2gdeep_hardware

Source: https://startupmag.co.uk/clotprotect-lands-1-2m-seed-to-reduce-preventable-patient-harm-from-blood-clots/